Volume 19 Number 6
30 June 2017

Home > Publications > Current Neuro-Oncology > Volume 19, Year 2017 > Number 6, 30 June

Sepúlveda-Sánchez JM, Vaz MÁ, Balañá C, Gil-Gil M, Reynés G, Gallego Ó, Martínez-García M, Vicente E, Quindós M, Luque R, Ramos A, Ruano Y, Pérez-Segura P, Benavides M, Sánchez-Gómez P, Hernández-Laín A.
Phase II trial of dacomitinib, a pan-HER (human epidermal growth factor receptor) tyrosine kinase inhibitor, in recurrent glioblastoma patients with EGFR amplification.
Neuro Oncol. 2017 Jun 1, 2017;19(11):1522-1531
. doi: 10.1093/neuonc/nox105. PMID: 28575464. Interventional study. ˍ

Barkhoudarian G.
A feasibility study of the Nativis Voyager system in patients with recurrent glioblastoma multiforme (GBM): Interim results of first-in-human study.
J Clin Oncol. 2017 Jun 2-6. 35, 2017 (suppl; abstr e13506)
ˍ. 2017 ASCO Annual Meeting. Meeting abstract. ˍ

Rizzo A, Donzelli S, Girgenti V, Sacconi A, Vasco C, Salmaggi A, Blandino G, Maschio M, Ciusani E.
In vitro antineoplastic effects of brivaracetam and lacosamide on human glioma cells.
J Exp Clin Cancer Res. 2017 Jun 6, 2017;36(1):76
. doi: 10.1186/s13046-017-0546-9. PMID: 28587680. Laboratory investigation. ˍ

Al Megren M, De Wit C, Al Qahtani M, Le Gal G, Carrier M.
Management of venous thromboembolism in patients with glioma.
Thromb Res. 2017 Jun 8, 2017;156:105-108
. doi: 10.1016/j.thromres.2017.06.010. PMID: 28624717. Observational study. ˍ

Li ZG, Mu HY.
Extracranial bone metastases from recurrent anaplastic astrocytoma on FDG PET/CT: A case report a care-compliant article.
Medicine (Baltimore). 2017 Jun [8], 2017;96(23):e7123
. doi: 10.1097/MD.0000000000007123. PMID: 28591062. Case report. ˍ

Kieran MW, Chisholm J, Casanova M, Brandes AA, Aerts I, Bouffet E, Bailey S, Leary S, MacDonald TJ, Mechinaud F, Cohen KJ, Riccardi R, Mason W, Hargrave D, Kalambakas S, Deshpande P, Tai F, Hurh E, Geoerger B.
Phase I study of oral sonidegib (LDE225) in pediatric brain and solid tumors and a phase II study in children and adults with relapsed medulloblastoma.
Neuro Oncol. 2017 Jun 9, 2017;19(11):1542-1552
. doi: 10.1093/neuonc/nox109. PMID: 28605510. Interventional study. ˍ

Nakajima H, Furukawa C, Chang YC, Ogata H, Magae J.
Delayed Growth Suppression and Radioresistance Induced by Long-Term Continuous Gamma Irradiation.
Radiat Res. 2017 Jun 9, 2017;188(2):181-190
. doi: 10.1667/RR14666.1. PMID: 28598290. Laboratory investigation. ˍ

Ng I, Tan CL, Yeo TT, Vellayappan B.
Rapidly Fatal Radiation-induced Glioblastoma.
Cureus. 2017 Jun 11, 2017;9(6):e1336
. doi: 10.7759/cureus.1336. PMID: 28706761. Case report. ˍ

Bavle A, Parsons DW.
From One to Many: Further Refinement of Medulloblastoma Subtypes Offers Promise for Personalized Therapy.
Cancer Cell. 2017 Jun 12, 2017;31(6):727-729
. doi: 10.1016/j.ccell.2017.05.013. PMID: 28609651. Comment. ˍ
Refers to: Cavalli FMG, et al., Intertumoral Heterogeneity within Medulloblastoma Subgroups.
Cancer Cell. 2017 Jun 12;31(6):737-754.e6. doi: 10.1016/j.ccell.2017.05.005. PMID: 28609654. Laboratory investigation. ˍ

Cavalli FMG, Remke M, Rampasek L, Peacock J, Shih DJH, Luu B, Garzia L, Torchia J, Nor C, Morrissy AS, Agnihotri S, Thompson YY, Kuzan-Fischer CM, Farooq H, Isaev K, Daniels C, Cho BK, Kim SK, Wang KC, Lee JY, Grajkowska WA, Perek-Polnik M, Vasiljevic A, Faure-Conter C, Jouvet A, Giannini C, Nageswara Rao AA, Li KKW, Ng HK, Eberhart CG, Pollack IF, Hamilton RL, Gillespie GY, Olson JM, Leary S, Weiss WA, Lach B, Chambless LB, Thompson RC, Cooper MK, Vibhakar R, Hauser P, van Veelen MC, Kros JM, French PJ, Ra YS, Kumabe T, López-Aguilar E, Zitterbart K, Sterba J, Finocchiaro G, Massimino M, Van Meir EG, Osuka S, Shofuda T, Klekner A, Zollo M, Leonard JR, Rubin JB, Jabado N, Albrecht S, Mora J, Van Meter TE, Jung S, Moore AS, Hallahan AR, Chan JA, Tirapelli DPC, Carlotti CG, Fouladi M, Pimentel J, Faria CC, Saad AG, Massimi L, Liau LM, Wheeler H, Nakamura H, Elbabaa SK, Perezpeña-Diazconti M, Chico Ponce de León F, Robinson S, Zapotocky M, Lassaletta A, Huang A, Hawkins CE, Tabori U, Bouffet E, Bartels U, Dirks PB, Rutka JT, Bader GD, Reimand J, Goldenberg A, Ramaswamy V, Taylor MD.
Intertumoral Heterogeneity within Medulloblastoma Subgroups.
Cancer Cell. 2017 Jun 12;31(6):737-754.e6
. doi: 10.1016/j.ccell.2017.05.005. PMID: 28609654. Laboratory investigation. ˍ

Kinon MD, Scoco A, Farinhas JM, Kobets A, Weidenheim KM, Yassari R, Lasala PA, Graber J.
Glioblastoma multiforme presenting with an open ring pattern of enhancement on MR imaging.
Surg Neurol Int. 2017 Jun 13, 2017;8:106
. doi: 10.4103/sni.sni_35_17. PMID: 28680725. Case report. ˍ

Sattar S, Akhunzada NZ, Javed G, Uddin Z, Khan YA.
Pilocytic astrocytoma: A rare presentation as intraventricular tumor.
Surg Neurol Int. 2017 Jun 13, 2017;8:116
. doi: 10.4103/sni.sni_468_16. PMID: 28680735. Case report. ˍ

Kepka L, Tyc-Szczepaniak D, Osowiecka K, Sprawka A, Trąbska-Kluch B, Czeremszynska B.
Quality of life after whole brain radiotherapy compared with radiosurgery of the tumor bed: results from a randomized trial.
Clin Transl Oncol. 2017 Jun 14, 2018;20(2):150-159
. doi: 10.1007/s12094-017-1703-5. PMID: 28616720. Interventional study. ˍ

Frandsen J, Orton A, Jensen R, Colman H, Cohen AL, Tward J, Shrieve DC, Suneja G.
Patterns of care and outcomes in gliosarcoma: an analysis of the National Cancer Database.
J Neurosurg. 2017 Jun 16, 2018;128(4):1133-1138
. doi: 10.3171/2016.12.JNS162291. PMID: 28621623. Observational study. ˍ

Gershanov S, Michowiz S, Toledano H, Yahav G, Barinfeld O, Hirshberg A, Ben-Zvi H, Mircus G, Salmon-Divon M, Fixler D, Goldenberg-Cohen N.
Fluorescence Lifetime Imaging Microscopy, a Novel Diagnostic Tool for Metastatic Cell Detection in the Cerebrospinal Fluid of Children with Medulloblastoma.
Sci Rep. 2017 Jun 16, 2017;7(1):3648
. doi: 10.1038/s41598-017-03892-6. PMID: 28623325. Observational study. ˍ.

Weller M.
Surgery for patients with "lower grade" glioma: putting assumptions, beliefs and convictions into perspective.
Ann Oncol. 2017 Jun 16, 2017;28(8):1696-1697
. doi: 10.1093/annonc/mdx295. PMID: 28637247. Comment. ˍ
Refers to: Jakola AS, et al., Surgical resection versus watchful waiting in low-grade gliomas.
Ann Oncol. 2017 May 5, 2017;28(8):1942-1948. doi: 10.1093/annonc/mdx230. PMID: 28475680. Observational study. ˍ

Tsang DS, Murphy ES, Ezell SE, Lucas JT Jr, Tinkle C, Merchant TE.
Craniospinal irradiation for treatment of metastatic pediatric low-grade glioma.
J Neurooncol. 2017 Jun 17, 2017;134(2):317-324
. doi: 10.1007/s11060-017-2525-6. PMID: 28623604. Observational study. ˍ

Kellermann SG, Hamisch CA, Rueß D, Blau T, Goldbrunner R, Treuer H, Grau SJ, Ruge MI.
Stereotactic biopsy in elderly patients: risk assessment and impact on treatment decision.
J Neurooncol. 2017 Jun 21, 2017;134(2):303-307
. doi: 10.1007/s11060-017-2522-9. PMID: 28639133. Observational study. ˍ

Gnekow AK, Walker DA, Kandels D, Picton S, Giorgio Perilongo, Grill J, Stokland T, Sandstrom PE, Warmuth-Metz M, Pietsch T, Giangaspero F, Schmidt R, Faldum A, Kilmartin D, De Paoli A, De Salvo GL; of the Low Grade Glioma Consortium and the participating centers.
A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma - A final report.
Eur J Cancer. 2017 Jun 23, 2017;81:206-225
. doi: 10.1016/j.ejca.2017.04.019. PMID: 28649001. Interventional study. ˍ

Kim WJ, Newman WC, Amankulor NM.
Phase I/II Trial of Combination of Temozolomide Chemotherapy and Immunotherapy With Fusions of Dendritic and Glioma Cells in Patients With Glioblastoma.
Neurosurgery. 2017 Jun 23, 2017;81(1):N11
. doi: 10.1093/neuros/nyx263. PMID: 28873996. Comment. ˍ
Refers to: Akasaki Y et al., Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma.
Cancer Immunol Immunother. 2016 Sep 29, 2016;65(12):1499-1509. doi: 10.1007/s00262-016-1905-7. PMID: 27688162. Interventional study.


Simonetti G, Silvani A, Fariselli L, Hottinger AF, Pesce GA, Prada F, Gaviani P.
Extra central nervous system metastases from glioblastoma: a new possible trigger event?
Neurol Sci. 2017 Jun 24, 2017;38(10):1873-1875
. doi: 10.1007/s10072-017-3036-0. PMID: 28647829. Case report. ˍ

Tan ZR, Long XY, Yang ZQ, Huang J, Hu QY, Yang HD, Li GL.
Younger age at surgery and lesser seizure frequency as prognostic factors for favorable seizure-related outcome after glioma resection in adults.
Oncotarget. 2017 Jun 27, 2017;8(55):93444-93449
. doi: 10.18632/oncotarget.18726. PMID: 29212163. Observational study. ˍ

Grossman SA, Kleinberg L.
A search for the "Goldilocks zone" with regard to the optimal duration of adjuvant temozolomide in patients with glioblastoma.
Neuro Oncol. 2017 Jun 30, 2017;19(8):1019-1020
. doi: 10.1093/neuonc/nox046. PMID: 28854621. Editorial. ˍ
Refers to: Blumenthal DT et al., Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG.
Neuro Oncol. 2017 Mar 24, 2017;19(8):1119-1126. doi: 10.1093/neuonc/nox025. PMID: 28371907. Observational study. ˍ